Vivozon Pharmaceutical Co., Ltd. (KOSDAQ: 082800)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,230.00
+15.00 (0.36%)
Oct 14, 2024, 11:46 AM KST

Vivozon Pharmaceutical Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-2,708-3,357-39,906-69,457-43,754-27,998
Upgrade
Depreciation & Amortization
3,4013,2283,6435,5522,1792,117
Upgrade
Loss (Gain) From Sale of Assets
527.83521-278.96229.9-337.982,156
Upgrade
Asset Writedown & Restructuring Costs
29.2132.626,18335,84710,9591,279
Upgrade
Loss (Gain) From Sale of Investments
771.36812.221,60213,67414,299-1,672
Upgrade
Loss (Gain) on Equity Investments
3,1162,8213,240691.352,35211,181
Upgrade
Stock-Based Compensation
---51.01277.47195.96-
Upgrade
Provision & Write-off of Bad Debts
-509.02-2,1114,9101,163282.5577.04
Upgrade
Other Operating Activities
6,5395,49713,2663,70812,38213,658
Upgrade
Change in Accounts Receivable
-1,960-4,419-2,278-2,7345,141103.87
Upgrade
Change in Inventory
-6,234-3,6652,750-3,756713.042,934
Upgrade
Change in Accounts Payable
3,8964,719835.48-81.21-2,840-208.18
Upgrade
Change in Other Net Operating Assets
-2,259-1,0882,760-2,6113,052-16,066
Upgrade
Operating Cash Flow
4,6102,992-3,323-17,4964,625-3,894
Upgrade
Capital Expenditures
-7,427-4,523-6,491-10,111-869.36-212.1
Upgrade
Sale of Property, Plant & Equipment
9,4959,410645-233.6437.0635.57
Upgrade
Cash Acquisitions
-----55,252-
Upgrade
Sale (Purchase) of Intangibles
-2,348-2,066-2,008-1,527-327.52-124.77
Upgrade
Investment in Securities
2,79113,886-26,880-24,261-7,3232,996
Upgrade
Other Investing Activities
251.15332.26-169.41-9,1961,832-40,013
Upgrade
Investing Cash Flow
3,12619,309-34,552-47,128-64,184-35,633
Upgrade
Short-Term Debt Issued
-7,6004,02018,4801,000-
Upgrade
Long-Term Debt Issued
--3,10010,00080,00031,300
Upgrade
Total Debt Issued
7,7967,6007,12028,48081,00031,300
Upgrade
Short-Term Debt Repaid
--17,900-6,000-11,300-6,726-
Upgrade
Long-Term Debt Repaid
--6,924-28,396-1,590-5,239-2,632
Upgrade
Total Debt Repaid
-16,059-24,824-34,396-12,890-11,965-2,632
Upgrade
Net Debt Issued (Repaid)
-8,263-17,224-27,27615,59069,03528,668
Upgrade
Issuance of Common Stock
-2,05958,1710.02-49,916
Upgrade
Repurchase of Common Stock
-18.19-18.19----
Upgrade
Other Financing Activities
-1,212-1,476-4,503-2,075-1,80023,490
Upgrade
Financing Cash Flow
-9,494-16,65926,39113,51567,235102,074
Upgrade
Foreign Exchange Rate Adjustments
-6.56-6.136.68576.64-675.98-65.95
Upgrade
Miscellaneous Cash Flow Adjustments
-0-----17,468
Upgrade
Net Cash Flow
-1,7655,635-11,448-50,5337,00045,014
Upgrade
Free Cash Flow
-2,817-1,532-9,814-27,6083,755-4,106
Upgrade
Free Cash Flow Margin
-3.46%-2.15%-19.03%-47.96%8.62%-9.13%
Upgrade
Free Cash Flow Per Share
-59.36-32.10-225.59-846.59143.39-195.38
Upgrade
Cash Interest Paid
1,2121,4643,2881,7231,696952.08
Upgrade
Cash Income Tax Paid
8.48-3.43-45.6736.03121.5150.43
Upgrade
Levered Free Cash Flow
-9,149-4,763-2,283-26,841-20,8886,699
Upgrade
Unlevered Free Cash Flow
-7,743-2,9481,012-22,280-14,14311,424
Upgrade
Change in Net Working Capital
4,1292,530-11,9964,21210,297-11,387
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.